Seagen Inc

NASDAQ:SGEN   3:59:53 PM EDT
174.00
-1.65 (-0.94%)
Earnings Announcements

Seagen Reports Second Quarter 2022 Financial Results

Published: 07/28/2022 21:20 GMT
Seagen Inc (SGEN) - Seagen Reports Second Quarter 2022 Financial Results.
Qtrly Total Revenues of $498 Million in 2q22, Including Net Product Sales of $432 Million.
Announced Positive Topline Results for Padcev With Keytruda As First-line Treatment for Advanced Urothelial Cancer.
Qtrly Loss per Share $0.47.
Q2 Earnings per Share View $-0.86, Revenue View $437.6 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $459.99 Million
Adjusted EPS is expected to be -$0.95

Next Quarter Revenue Guidance is expected to be $459.17 Million
Next Quarter EPS Guidance is expected to be -$1.05

More details on our Analysts Page.